Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janna Heide

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|April 6, 2019
Comprehensive Review of Human <i>Plasmodium falciparum</i>-Specific CD8+ T Cell EpitopesJanna Heide, Kerrie C Vaughan, Alessandro Sette, et al.
Clinical and Experimental Immunology|January 12, 2022
Deciphering the Plasmodium falciparum malaria-specific CD4+ T-cell response: ex vivo detection of high frequencies of PD-1+TIGIT+ EXP1-specific CD4+ T cells using a novel HLA-DR11-restricted MHC class II tetramerSophia Schulte, Janna Heide, Christin Ackermann, et al.
Frontiers in Immunology|February 11, 2020
Detection of EXP1-Specific CD4+ T Cell Responses Directed Against a Broad Range of Epitopes Including Two Promiscuous MHC Class II Binders During Acute <i>Plasmodium falciparum</i> MalariaJanna Heide, Nils H Wildner, Christin Ackermann, et al.
Cancer Research|November 5, 2021
Neoadjuvant Chemotherapy Induces Genomic and Transcriptomic Changes in Ovarian CancerMelissa Javellana, Mark A Eckert, Janna Heide, et al.
Plos Pathogens|January 5, 2022
Correction: Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19Janna Heide, Sophia Schulte, Matin Kohsar, et al.
Plos Pathogens|September 16, 2021
Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19Janna Heide, Sophia Schulte, Matin Kohsar, et al.
The Journal of Infectious Diseases|September 25, 2018
Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II-Restricted, Hepatitis Delta Virus (HDV)-Specific T-Cell Responses Regardless of Clinical StatusJohanna Landahl, Jan Hendrik Bockmann, Christoph Scheurich, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2020
Sustained Response After Remdesivir and Convalescent Plasma Therapy in a B-Cell-Depleted Patient With Protracted Coronavirus Disease 2019 (COVID-19)Jakob Malsy, Luzia Veletzky, Janna Heide, et al.
Clinical & Translational Immunology|September 6, 2021
Landscape of T-cell repertoires with public COVID-19-associated T-cell receptors in pre-pandemic risk cohortsDonjete Simnica, Christoph Schultheiß, Malte Mohme, et al.
Nature|May 14, 2025
Radiation-induced amphiregulin drives tumour metastasisAndrás Piffkó, Kaiting Yang, Arpit Panda, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|April 6, 2019
Comprehensive Review of Human <i>Plasmodium falciparum</i>-Specific CD8+ T Cell EpitopesJanna Heide, Kerrie C Vaughan, Alessandro Sette, et al.
Clinical and Experimental Immunology|January 12, 2022
Deciphering the Plasmodium falciparum malaria-specific CD4+ T-cell response: ex vivo detection of high frequencies of PD-1+TIGIT+ EXP1-specific CD4+ T cells using a novel HLA-DR11-restricted MHC class II tetramerSophia Schulte, Janna Heide, Christin Ackermann, et al.
Frontiers in Immunology|February 11, 2020
Detection of EXP1-Specific CD4+ T Cell Responses Directed Against a Broad Range of Epitopes Including Two Promiscuous MHC Class II Binders During Acute <i>Plasmodium falciparum</i> MalariaJanna Heide, Nils H Wildner, Christin Ackermann, et al.
Cancer Research|November 5, 2021
Neoadjuvant Chemotherapy Induces Genomic and Transcriptomic Changes in Ovarian CancerMelissa Javellana, Mark A Eckert, Janna Heide, et al.
Plos Pathogens|January 5, 2022
Correction: Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19Janna Heide, Sophia Schulte, Matin Kohsar, et al.
Plos Pathogens|September 16, 2021
Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19Janna Heide, Sophia Schulte, Matin Kohsar, et al.
The Journal of Infectious Diseases|September 25, 2018
Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II-Restricted, Hepatitis Delta Virus (HDV)-Specific T-Cell Responses Regardless of Clinical StatusJohanna Landahl, Jan Hendrik Bockmann, Christoph Scheurich, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2020
Sustained Response After Remdesivir and Convalescent Plasma Therapy in a B-Cell-Depleted Patient With Protracted Coronavirus Disease 2019 (COVID-19)Jakob Malsy, Luzia Veletzky, Janna Heide, et al.
Clinical & Translational Immunology|September 6, 2021
Landscape of T-cell repertoires with public COVID-19-associated T-cell receptors in pre-pandemic risk cohortsDonjete Simnica, Christoph Schultheiß, Malte Mohme, et al.
Nature|May 14, 2025
Radiation-induced amphiregulin drives tumour metastasisAndrás Piffkó, Kaiting Yang, Arpit Panda, et al.
Pageof 2